Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: A novel path to cancer prevention.

International journal of cancer·2025

Same author

Cholesterol-targeting Wnt-β-catenin signaling inhibitors for colorectal cancer.

Nature chemical biology·2025

Same author

Noncanonical PI(4,5)P<sub>2</sub> coordinates lysosome positioning through cholesterol trafficking.

bioRxiv : the preprint server for biology·2025

Same author

Targeting lipid-protein interaction to treat Syk-mediated acute myeloid leukemia.

Nature chemical biology·2022

Same author

Photostable and Orthogonal Solvatochromic Fluorophores for Simultaneous <i>In Situ</i> Quantification of Multiple Cellular Signaling Molecules.

ACS chemical biology·2020

Same journal

Why microglial repair programs fade.

Cell research·2026

Same journal

Atypical signaling, ligand recognition and selective agonist discovery of complement receptor C5aR2.

Cell research·2026

Same journal

One drug, five targets.

Cell research·2026

Same journal

Smooth emotional response: amygdalar neurovascular coupling drives stress encoding.

Cell research·2026

Same journal

Liquid surrogates of spatial tumor ecosystems.

Cell research·2026

Same journal

MitoCatch directs mitochondria delivery and prevents cell degeneration.

Cell research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 18, 2026

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

Boosting immunotherapy by restoring cryptic APC function

¹Department of Chemistry, University of Illinois Chicago, Chicago, IL, USA. wcho@uic.edu.

|January 16, 2026

Summary

No abstract available in PubMed .

More Related Videos

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014

Related Experiment Videos

Last Updated: Jan 18, 2026

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014